01 6Knight Therapeutics Inc
01 22463938
02 22549730
03 22812649
01 6NALOXEGOL OXALATE
01 6TABLET
01 22022-10-18
02 22024-12-16
03 22031-09-29
Patent Expiration Date : 2022-10-18
Date Granted : 2011-08-09
Brand Name : MOVANTIK
Patent Number : 2463938
Filing Date : 2002-10-18
Strength per Unit : 12.5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-10-18
Date Granted : 2011-08-09
Patent Expiration Date : 2024-12-16
Date Granted : 2012-02-14
Brand Name : MOVANTIK
Patent Number : 2549730
Filing Date : 2004-12-16
Strength per Unit : 12.5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-12-16
Date Granted : 2012-02-14
Patent Expiration Date : 2031-09-29
Date Granted : 2016-03-01
Brand Name : MOVANTIK
Patent Number : 2812649
Filing Date : 2011-09-29
Strength per Unit : 12.5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-09-29
Date Granted : 2016-03-01
Patent Expiration Date : 2022-10-18
Date Granted : 2011-08-09
Brand Name : MOVANTIK
Patent Number : 2463938
Filing Date : 2002-10-18
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-10-18
Date Granted : 2011-08-09
Patent Expiration Date : 2024-12-16
Date Granted : 2012-02-14
Brand Name : MOVANTIK
Patent Number : 2549730
Filing Date : 2004-12-16
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-12-16
Date Granted : 2012-02-14
Patent Expiration Date : 2031-09-29
Date Granted : 2016-03-01
Brand Name : MOVANTIK
Patent Number : 2812649
Filing Date : 2011-09-29
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-09-29
Date Granted : 2016-03-01
